TROG 17.06 - SC.24 - TROG Cancer Research

Read Roland's story about participating in a prostate cancer trial

Catch up with the news from our 2026 Annual Scientific Meeting

Read about TROG's new President-Elect and Board Members

TROG Research Excellence Award winners announced.

First participant recruited for new lung cancer trial

Secondary Data Analysis grant recipient announced

By w.paterson
23 June, 2021
0 Comments

A Phase III Randomized Feasibility Study Comparing Stereotactic Body Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) For Patients With Spinal Metastases

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Related Post

14 April, 2026

Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices

LATEST NEWS: 14 April 2026 TROG has made a

9 April, 2026

Vale Professor Jim Denham OAM, TROG founder and world-class researcher

9 April 2026 TROG Cancer Research honours the life